DK457676A - Fremgangsmade til fremstilling af antibakterielt virksomme forbindelser - Google Patents

Fremgangsmade til fremstilling af antibakterielt virksomme forbindelser

Info

Publication number
DK457676A
DK457676A DK457676A DK457676A DK457676A DK 457676 A DK457676 A DK 457676A DK 457676 A DK457676 A DK 457676A DK 457676 A DK457676 A DK 457676A DK 457676 A DK457676 A DK 457676A
Authority
DK
Denmark
Prior art keywords
procedure
active compounds
antibacterial active
preparing antibacterial
preparing
Prior art date
Application number
DK457676A
Other languages
Danish (da)
English (en)
Inventor
R J Ponsford
T T Howarth
I Stirling
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of DK457676A publication Critical patent/DK457676A/da
Priority to DK398780A priority Critical patent/DK398780A/da
Priority to DK398880A priority patent/DK398880A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
DK457676A 1975-10-13 1976-10-12 Fremgangsmade til fremstilling af antibakterielt virksomme forbindelser DK457676A (da)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DK398780A DK398780A (da) 1975-10-13 1980-09-19 Fremgangsmaade til fremstilling af antibakterielt virksomme forbindelser
DK398880A DK398880A (da) 1975-10-13 1980-09-19 Anvendelse af clavudiener som mellemprodukt ved fremstillingen af clavulansyrederivater

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB41887/75A GB1566706A (en) 1975-10-13 1975-10-13 Clavulanic acid derivatives

Publications (1)

Publication Number Publication Date
DK457676A true DK457676A (da) 1977-04-14

Family

ID=10421810

Family Applications (1)

Application Number Title Priority Date Filing Date
DK457676A DK457676A (da) 1975-10-13 1976-10-12 Fremgangsmade til fremstilling af antibakterielt virksomme forbindelser

Country Status (28)

Country Link
US (3) US4256638A (zh)
JP (1) JPS5248686A (zh)
AR (1) AR213294A1 (zh)
AT (1) AT352874B (zh)
AU (1) AU503489B2 (zh)
BE (1) BE847044A (zh)
CA (1) CA1094563A (zh)
CH (2) CH634323A5 (zh)
DD (1) DD126929A5 (zh)
DE (1) DE2646003A1 (zh)
DK (1) DK457676A (zh)
ES (2) ES452361A1 (zh)
FI (1) FI762895A (zh)
FR (1) FR2327775A1 (zh)
GB (1) GB1566706A (zh)
GR (1) GR61674B (zh)
HU (1) HU175046B (zh)
IE (1) IE43840B1 (zh)
IL (1) IL50618A (zh)
MX (1) MX4688E (zh)
NL (1) NL7611206A (zh)
NO (3) NO763472L (zh)
NZ (1) NZ182190A (zh)
PT (1) PT65707B (zh)
SE (3) SE7611047L (zh)
SU (1) SU639454A3 (zh)
ZA (1) ZA765901B (zh)
ZM (1) ZM12276A1 (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1091113B (it) * 1976-10-25 1985-06-26 Glaxo Lab Ltd Composizioni terapeutiche a base di n-acil-derivati di acido clavulanico e procedimento per produrle
US4359473A (en) 1977-04-22 1982-11-16 Beecham Group Limited α-Amino deoxy clavulanic acid antibacterial agents
GB1604822A (en) * 1977-04-22 1981-12-16 Beecham Group Ltd N-monosubstituted-9-amino-9-deoxyclavulanic acid derivative
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
EP0005014A1 (en) * 1978-04-22 1979-10-31 Beecham Group Plc Clavulanic acid derivatives, preparation and compositions
DE2963534D1 (en) * 1978-07-29 1982-10-07 Beecham Group Plc Clavulanic acid derivatives, a process for their preparation, their use, and pharmaceutical compositions containing them
EP0008877B1 (en) * 1978-09-09 1983-10-26 Beecham Group Plc Derivatives of clavulanic acid, a process for their preparation and their use
EP0008884B1 (en) * 1978-09-09 1983-08-17 Beecham Group Plc Derivatives of clavulanic acid, a process for their preparation and their compositions
DE2966347D1 (en) * 1978-09-09 1983-12-01 Beecham Group Plc Clavulanic acid derivatives and process for their preparation
EP0010369B1 (en) * 1978-10-25 1983-07-20 Beecham Group Plc Clavulanic acid derivatives, processes for their preparation and pharmaceutical compositions containing them
IL60343A0 (en) * 1979-07-02 1980-09-16 Beecham Group Ltd Clavulanic acid derivatives,their preparation and pharmaceutical compositions containing them
DK330880A (da) * 1979-08-03 1981-02-04 Beecham Group Ltd Fremgangsmaade til fremstilling af clavulansyrederivater
EP0028083B1 (en) * 1979-10-26 1984-02-08 Beecham Group Plc Derivatives of clavulanic acid, a process for their preparation and pharmaceutical compositions containing them
EP0053893B1 (en) * 1980-12-09 1985-03-20 Beecham Group Plc Derivatives of clavulanic acid, their preparation and their use
US4562182A (en) * 1980-12-23 1985-12-31 Beecham Group P.L.C. Compounds containing beta-lactams
JPS57143194A (en) * 1981-02-27 1982-09-04 Matsushita Electric Ind Co Ltd Blower
EP0062407A1 (en) * 1981-03-10 1982-10-13 Beecham Group Plc Therapeutic compounds containing beta-lactams
JPH0495698U (zh) * 1991-01-21 1992-08-19
GB9518917D0 (en) * 1995-09-15 1995-11-15 Smithkline Beecham Plc Compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1424186A (en) * 1971-10-08 1976-02-11 Beecham Group Ltd Penicillins
US3925363A (en) * 1974-01-17 1975-12-09 Merck & Co Inc Process for epimerizing penicillin compounds, and related products
US4051132A (en) * 1974-01-23 1977-09-27 Merck & Co., Inc. Process for epimerizing beta-lactam antibiotic compounds by means of an acid quench
GB1585165A (en) * 1976-06-29 1981-02-25 Leo Pharm Prod Ltd Derivatives of 6-amidino penicillanic acid
IL54859A (en) * 1977-06-21 1982-01-31 Rech Applications Therap Derivatives of amidinopenicillanic acid,their production and pharmaceutical compositions containing them
DE2963717D1 (en) * 1978-05-06 1982-11-04 Beecham Group Plc Carbapenem derivatives, a process for their preparation and pharmaceutical compositions containing them
US4244965A (en) * 1978-06-15 1981-01-13 Beecham Group Limited Azetidinoyl ethers
US4252722A (en) * 1979-08-08 1981-02-24 Merck & Co., Inc. Process for the preparation of 6-hydroxymethyl-2-(β-aminoethylthio)-1-carbadethiapen-2-em-3-carboxylic acid
US4237051A (en) * 1979-04-19 1980-12-02 Schering Corporation Stereospecific production of 6- or 7-carbon-substituted-β-lactams
US4231928A (en) * 1979-04-24 1980-11-04 Bristol-Myers Company Antibacterial agents

Also Published As

Publication number Publication date
US4438101A (en) 1984-03-20
ES452361A1 (es) 1978-01-01
IE43840B1 (en) 1981-06-03
US4382084A (en) 1983-05-03
NO763472L (zh) 1977-04-14
GR61674B (en) 1978-12-05
AR213294A1 (es) 1979-01-15
JPS5248686A (en) 1977-04-18
SE7611047L (sv) 1977-04-14
SE8004330L (sv) 1980-06-10
FI762895A (zh) 1977-04-14
MX4688E (es) 1982-08-02
FR2327775A1 (fr) 1977-05-13
IE43840L (en) 1977-04-13
AU1858276A (en) 1978-04-20
SE8004329L (sv) 1980-06-10
PT65707B (en) 1978-04-17
JPS612670B2 (zh) 1986-01-27
ATA753476A (de) 1979-03-15
NZ182190A (en) 1979-03-16
DD126929A5 (zh) 1977-08-24
NL7611206A (nl) 1977-04-15
PT65707A (en) 1976-11-01
ZA765901B (en) 1977-09-28
GB1566706A (en) 1980-05-08
NO802662L (no) 1977-04-14
BE847044A (fr) 1977-04-07
AU503489B2 (en) 1979-09-06
CA1094563A (en) 1981-01-27
DE2646003A1 (de) 1977-04-21
AT352874B (de) 1979-10-10
US4256638A (en) 1981-03-17
IL50618A0 (en) 1976-12-31
ZM12276A1 (en) 1977-07-21
CH634323A5 (de) 1983-01-31
FR2327775B1 (zh) 1978-11-17
NO802661L (no) 1977-04-14
SU639454A3 (ru) 1978-12-25
HU175046B (hu) 1980-05-28
ES463974A1 (es) 1978-12-16
CH639665A5 (de) 1983-11-30
IL50618A (en) 1979-09-30

Similar Documents

Publication Publication Date Title
DK143706C (da) Fremgangsmaade til fremstilling af svovlholdige organosiliciumforbindelser
DK457676A (da) Fremgangsmade til fremstilling af antibakterielt virksomme forbindelser
DK484576A (da) Fremgangsmade til fremstilling af 2-aroyl-3-phenyl-benzothiophenforbindelser
DK236275A (da) Fremgangsmade til fremstilling af antibakterielle midler
DK517776A (da) Fremgangsmade til femstilling af heterocycliske forbindelser
DK457576A (da) Fremgangsmade til fremstilling af antibakterielle midler
DK415676A (da) Fremgangsmade til fremstilling af pilocarpiniumsalte
DK272676A (da) Fremgangsmade til fremstilling af cephalosporinforbindelser
DK171678A (da) Fremgangsmaade til fremstilling af antibakterielt virksomme forbindelser
DK243676A (da) Fremgangsmade til fremstilling af pyrrolforbindelser
DK164476A (da) Fremgangsmade til fremstilling af piperazinylpyrazinforbindelser
DK215676A (da) Fremgangsmade til fremstilling af rifamycinforbindelser
DK324776A (da) Fremgangsmade til fremstilling af 3-cyanoimino-3-aminopropionitriler
DK193775A (da) Fremgangsmade til fremstilling af antibakterielle midler
DK372576A (da) Fremgangsmade til fremstilling af polyaminforbindelser
DK305876A (da) Fremgangsmade til fremstilling af l-pyroglutamyl-l-prolinamid
DK364177A (da) Fremgangsmaade til fremstilling af antibakterielt virksomme forbindelser
DK457376A (da) Fremgangsmade til fremstilling af antibakterielt virksomme forbindelser
DK220276A (da) Fremgangsmade til fremstilling af rifamycinforbindelser
DK143137C (da) Fremgangsmaade til fremstilling af phosphitchlorider
DK143281C (da) Fremgangsmaade til fremstilling af phosphitchlorider
DK511376A (da) Fremgangsmade til fremstilling af imidazolforbindelser
DK181778A (da) Fremgangsmaade til fremstilling af antibakterielt virksomme forbindelser
DK223875A (da) Fremgangsmade til fremstilling af antibakterielle midler
DK508976A (da) Fremgangsmade til fremstilling af rifamycinforbindelser